Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP541385.RAH6DKPEgQlq7CS1iM2ihlLCb8novrzo1NeKUEQsmiXEw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP541385.RAH6DKPEgQlq7CS1iM2ihlLCb8novrzo1NeKUEQsmiXEw130_assertion type Assertion NP541385.RAH6DKPEgQlq7CS1iM2ihlLCb8novrzo1NeKUEQsmiXEw130_head.
- NP541385.RAH6DKPEgQlq7CS1iM2ihlLCb8novrzo1NeKUEQsmiXEw130_assertion description "[We postulated that compounds that inhibit a distal effector in the mitogen-activated protein kinase (MAPK) pathway would inhibit growth and tumorigenicity of human thyroid cancer cell lines with mutations of RET or BRAF.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP541385.RAH6DKPEgQlq7CS1iM2ihlLCb8novrzo1NeKUEQsmiXEw130_provenance.
- NP541385.RAH6DKPEgQlq7CS1iM2ihlLCb8novrzo1NeKUEQsmiXEw130_assertion evidence source_evidence_literature NP541385.RAH6DKPEgQlq7CS1iM2ihlLCb8novrzo1NeKUEQsmiXEw130_provenance.
- NP541385.RAH6DKPEgQlq7CS1iM2ihlLCb8novrzo1NeKUEQsmiXEw130_assertion SIO_000772 16551863 NP541385.RAH6DKPEgQlq7CS1iM2ihlLCb8novrzo1NeKUEQsmiXEw130_provenance.
- NP541385.RAH6DKPEgQlq7CS1iM2ihlLCb8novrzo1NeKUEQsmiXEw130_assertion wasDerivedFrom befree-2016 NP541385.RAH6DKPEgQlq7CS1iM2ihlLCb8novrzo1NeKUEQsmiXEw130_provenance.
- NP541385.RAH6DKPEgQlq7CS1iM2ihlLCb8novrzo1NeKUEQsmiXEw130_assertion wasGeneratedBy ECO_0000203 NP541385.RAH6DKPEgQlq7CS1iM2ihlLCb8novrzo1NeKUEQsmiXEw130_provenance.